PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.\', \'Laboratory of Biomolecular Science, and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan.\', \'Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan; Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd., Osaka 561-0825, Japan.\', \'Laboratory of Immune Regulation, WPI Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan.\', \'Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan.\', \'Laboratory of Biomolecular Science, and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan; Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Sapporo 060-0812, Japan.\', \'Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan.\', \'Department of Pathology, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.\', \'Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka 812-8582, Japan.\', \'Pathogen Genomic Center, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.\', \'Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan; Department of Life Science and Medical Bioscience, Waseda University, Tokyo 162-8480, Japan.\', \'Department of Virology I, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.\', \'Chromosome Engineering Research Center, Tottori University, Tottori 683-8503, Japan.\', \'Chromosome Engineering Research Center, Tottori University, Tottori 683-8503, Japan; Division of Genome and Cellular Functions, Department of Molecular and Cellular Biology, School of Life Science, Faculty of Medicine, Tottori University, Tottori 683-8503, Japan.\', \'Trans Chromosomics Inc., Tottori 683-8503, Japan.\', \'Laboratory of Virus Control, Center for Infectious Diseases Education and Research, Osaka University, Osaka 565-0871, Japan.\', \'Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka 812-8582, Japan; Laboratory of Medical Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.\', \'Laboratory of Biomolecular Science, and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan; Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Sapporo 060-0812, Japan. Electronic address: maenaka@pharm.hokudai.ac.jp.\', \'Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan. Electronic address: ytakahas@niid.go.jp.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1074-7613(21)00359-910.1016/j.immuni.2021.08.025
?:hasPublicationType
?:journal
  • Immunity
is ?:pmid of
?:pmid
?:pmid
  • 34508662
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 13.393
?:rankingScore_hIndex
  • 342
is ?:relation_isRelatedTo_publication of
?:title
  • A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all